"ANGIOLINE" and Almazov Centre signed a Memorandum "On Cooperation"
As part of the activities for the prevention and control of socially significant diseases, on July 17, LLC Angioline and the Federal State Budgetary Institution Almazov National Medical Research Center signed a Memorandum “On Cooperation”. In accordance with the memorandum, the parties will create joint working groups that will develop and organize the production of innovative medical products, conduct preclinical and clinical trials, organize scientific, educational and outreach activities on the prevention and control of socially significant diseases. “The signing of the Memorandum "On Cooperation" with the Almazov Center is a landmark event for the Angioline Company, as it opens up new opportunities for the development of the production of the most popular innovative medical products in close cooperation with the leading scientific center of the country,” the manager said on business development of LLC Angioline, Vladislav Markelov.